The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)
杰克逊实验室基因敲除小鼠生产和表型项目 (JAX KOMP2)
基本信息
- 批准号:10386984
- 负责人:
- 金额:$ 239.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-11 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAdultAgeAwardBiologicalBreedingCOVID-19COVID-19 outbreakCatalogsCommunitiesDataData Coordinating CenterDiseaseEmbryoEncyclopediasFundingGenesGeneticGoalsGrantHealthHeterozygoteHomozygoteHumanHuman ResourcesInternationalKnock-outKnockout MiceKnowledgeLaboratoriesLinkMusPhasePhenotypeProceduresProductionPublic HealthResourcesRoleServicesTestingThe Jackson LaboratoryWorld Health Organizationagedcohortdata pipelinegene functioninternational centerknockout genemedical specialtiesmutantpandemic diseasephenotypic dataprogramsscreeningviral transmission
项目摘要
PROJECT SUMMARY
The goal of The Jackson Laboratory (JAX) Knockout Mouse Phenotyping Project phase 2 (KOMP2) is to
contribute to the international effort of creating a comprehensive catalog of mammalian gene function obtained
through the creation of gene knockouts and execution of a high-throughput phenotyping pipeline. At JAX an
Early Adult Pipeline (EAP) is being used to phenotype mice up to 17 weeks of age with a goal of screening 1,000
mutant lines by the end of the current 5-year project period. Further, during this award period, a subset of 150
lines is being aged out to 18 months and phenotyped using a Late Adult Pipeline (LAP) to detect age-associated
phenotypes. Nonviable and subviable lines are also being phenotyped using specialty embryonic phenotyping
pipelines. On March 11, 2020 the World Health Organization (WHO) declared the outbreak of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) a world-wide pandemic. A consequence
of the pandemic has been a reduction of our available personnel and services needed to reach our original goals.
Restrictions during the pandemic have curtailed the breeding and phenotyping activity on the JAX KOMP2 center.
We have maintained a lower level of breeding of cohorts and reduced phenotyping of mice. In addition, in order
to maximize physical distancing and operate in a way that mitigates viral transmission and spread, we have
discontinued procedures that require close contact between staff. Due to the pandemic, we are short of the total
number of lines projected to have been phenotyped and on the number of lines with full cohorts for all tests. The
purpose of this request for a funded extension beyond the current project period is to complete the initial goals
of creating and phenotyping 1000 lines of KO mice. We project that at the end of the original grant period that
860 lines of mice will have completed the EAP pipeline and that LAP phenotyping data from all 150 lines will be
collected. The Specific Aims of this funded extension are to breed and populate the EAP from the remaining 140
mouse lines to bring our total to 1000 lines. Approximately 70% of the lines (~100 lines) will be fully viable and
will therefore be phenotyped as homozygotes. The remaining 30% of the lines (~40 lines) be non-viable or
subviable and will therefore enter the EAP as heterozygotes. These 40 lines will also be used to populate our
embryo lethal phenotyping pipeline. QC analysis will be performed on both the EAP and LAP data and exported
to the Data Coordination Center of the International Mouse Phenotyping Consortium.
项目摘要
杰克逊实验室(JAX)敲除鼠标表型项目2阶段(KOMP2)的目标是
有助于创建获得哺乳动物基因功能的全面目录的国际努力
通过创建基因敲除和高通量表型管道的执行。在Jax an
早期的成人管道(EAP)用于表型小鼠长达17周龄的小鼠,目的是筛查1,000
当前5年项目期结束时,突变线。此外,在此颁奖期间,150个子集
线条已陈化到18个月,并使用晚期管道(LAP)进行表型,以检测与年龄相关的
表型。使用特种胚胎表型也表现出不可行且可下的线
管道。 2020年3月11日,世界卫生组织(WHO)宣布爆发严重的急性
呼吸道综合征冠状病毒2(SARS-COV-2)疾病(COVID-19)全球大流行。结果
大流行是减少了我们实现我们最初目标所需的可用人员和服务。
大流行期间的限制减少了JAX KOMP2中心的繁殖和表型活性。
我们维持了较低的同类菌种繁殖水平和小鼠表型的降低。另外,按顺序
为了以减轻病毒传播和传播的方式最大化身体距离和操作,我们有
停产的程序需要工作人员之间的密切联系。由于大流行,我们缺乏总数
预计将进行表型的线数,并在所有测试中具有完整队列的线数。这
本请求的目的超出了当前项目期限以外的资助扩展名
创建和表型1000行KO小鼠。我们预测,在原始赠款期结束时
860行小鼠将完成EAP管道,并且所有150行的LAP表型数据将是
集。这项资助的扩展的具体目的是繁殖和填充其余140的EAP
鼠标线使我们的总数达到1000行。大约70%的线(〜100行)将完全可行,并且
因此,将被表型为纯合子。其余30%的线(〜40行)是不可行的或
可亚科,因此将作为杂合子进入EAP。这40行也将用于填充我们的
胚胎致命的表型管道。 QC分析将对EAP和LAP数据进行,并导出
到国际小鼠表型联盟的数据协调中心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT E BRAUN其他文献
ROBERT E BRAUN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT E BRAUN', 18)}}的其他基金
The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)
杰克逊实验室基因敲除小鼠生产和表型项目 (JAX KOMP2)
- 批准号:
10431514 - 财政年份:2021
- 资助金额:
$ 239.17万 - 项目类别:
The Jackson Laboratory KOMP2 Phenotyping Center
杰克逊实验室 KOMP2 表型中心
- 批准号:
8914802 - 财政年份:2011
- 资助金额:
$ 239.17万 - 项目类别:
The Jackson Laboratory KOMP2 Phenotyping Center
杰克逊实验室 KOMP2 表型中心
- 批准号:
9059842 - 财政年份:2011
- 资助金额:
$ 239.17万 - 项目类别:
The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)
杰克逊实验室基因敲除小鼠生产和表型项目 (JAX KOMP2)
- 批准号:
9754888 - 财政年份:2011
- 资助金额:
$ 239.17万 - 项目类别:
The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)
杰克逊实验室基因敲除小鼠生产和表型项目 (JAX KOMP2)
- 批准号:
10517971 - 财政年份:2011
- 资助金额:
$ 239.17万 - 项目类别:
The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)
杰克逊实验室基因敲除小鼠生产和表型项目 (JAX KOMP2)
- 批准号:
10683282 - 财政年份:2011
- 资助金额:
$ 239.17万 - 项目类别:
The Jackson Laboratory KOMP2 Phenotyping Center
杰克逊实验室 KOMP2 表型中心
- 批准号:
8833517 - 财政年份:2011
- 资助金额:
$ 239.17万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 239.17万 - 项目类别:
SARS-CoV-2 in Pregnancy: Comparison of Natural Infection and Hybrid Immunity in Mother-Infant Pairs
妊娠期 SARS-CoV-2:母婴对自然感染和混合免疫的比较
- 批准号:
10723697 - 财政年份:2023
- 资助金额:
$ 239.17万 - 项目类别:
Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations
SARS-CoV-2 感染和遗传变异的相互作用对祖先和混血人群认知能力下降和阿尔茨海默病风险的影响
- 批准号:
10628505 - 财政年份:2023
- 资助金额:
$ 239.17万 - 项目类别:
CNS-mediated fever after Adolescent Intermittent Ethanol
青少年间歇性饮酒后中枢神经系统介导的发热
- 批准号:
10607154 - 财政年份:2023
- 资助金额:
$ 239.17万 - 项目类别:
Impact of SARS-CoV-2 infection on respiratory viral immune responses in children with and without asthma
SARS-CoV-2 感染对患有和不患有哮喘的儿童呼吸道病毒免疫反应的影响
- 批准号:
10568344 - 财政年份:2023
- 资助金额:
$ 239.17万 - 项目类别: